The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease

Detalhes bibliográficos
Autor(a) principal: Vanhaecht, Kris
Data de Publicação: 2010
Outros Autores: Sermeus, Walter, Peers, Jan, Lodewijckx, Cathy, Deneckere, Svin, Leigheb, Fabrizio, Decramer, Marc, Panella, Massimiliano, Doocey, Antoinette, Boto, Paulo Alexandre Faria, Mendez, Rita Veloso, the EQCP Study Group
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.1186/1745-6215-11-111
Resumo: Background: Hospital treatment of chronic obstructive pulmonary disease (COPD) frequently does not follow published evidences. This lack of adherence can contribute to the high morbidity, mortality and readmissions rates. The European Quality of Care Pathway (EQCP) study on acute exacerbations of COPD (NTC00962468) is undertaken to determine how care pathways (CP) as complex intervention for hospital treatment of COPD affects care variability, adherence to evidence based key interventions and clinical outcomes.Methods: An international cluster Randomized Controlled Trial (cRCT) will be performed in Belgium, Italy, Ireland and Portugal. Based on the power analysis, a sample of 40 hospital teams and 398 patients will be included in the study. In the control arm of the study, usual care will be provided. The experimental teams will implement a CP as complex intervention which will include three active components: a formative evaluation of the quality and organization of care, a set of evidence based key interventions, and support on the development and implementation of the CP. The main outcome will be six-month readmission rate. As a secondary endpoint a set of clinical outcome and performance indicators (including care process evaluation and team functioning indicators) will be measured in both groups.Discussion: The EQCP study is the first international cRCT on care pathways. The design of the EQCP project is both a research study and a quality improvement project and will include a realistic evaluation framework including process analysis to further understand why and when CP can really work.
id RCAP_d73a69bce0f6fd8c20a41dd0e3b3ebf7
oai_identifier_str oai:run.unl.pt:10362/39949
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary DiseaseRationale and design of a cluster randomized controlled trialMedicine (miscellaneous)Pharmacology (medical)Background: Hospital treatment of chronic obstructive pulmonary disease (COPD) frequently does not follow published evidences. This lack of adherence can contribute to the high morbidity, mortality and readmissions rates. The European Quality of Care Pathway (EQCP) study on acute exacerbations of COPD (NTC00962468) is undertaken to determine how care pathways (CP) as complex intervention for hospital treatment of COPD affects care variability, adherence to evidence based key interventions and clinical outcomes.Methods: An international cluster Randomized Controlled Trial (cRCT) will be performed in Belgium, Italy, Ireland and Portugal. Based on the power analysis, a sample of 40 hospital teams and 398 patients will be included in the study. In the control arm of the study, usual care will be provided. The experimental teams will implement a CP as complex intervention which will include three active components: a formative evaluation of the quality and organization of care, a set of evidence based key interventions, and support on the development and implementation of the CP. The main outcome will be six-month readmission rate. As a secondary endpoint a set of clinical outcome and performance indicators (including care process evaluation and team functioning indicators) will be measured in both groups.Discussion: The EQCP study is the first international cRCT on care pathways. The design of the EQCP project is both a research study and a quality improvement project and will include a realistic evaluation framework including process analysis to further understand why and when CP can really work.Escola Nacional de Saúde Pública (ENSP)RUNVanhaecht, KrisSermeus, WalterPeers, JanLodewijckx, CathyDeneckere, SvinLeigheb, FabrizioDecramer, MarcPanella, MassimilianoDoocey, AntoinetteBoto, Paulo Alexandre FariaMendez, Rita Velosothe EQCP Study Group2018-06-21T22:07:14Z2010-11-192010-11-19T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.1186/1745-6215-11-111eng1745-6215PURE: 4407843http://www.scopus.com/inward/record.url?scp=78349261954&partnerID=8YFLogxKhttps://doi.org/10.1186/1745-6215-11-111info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:21:55Zoai:run.unl.pt:10362/39949Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:31:12.775330Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
Rationale and design of a cluster randomized controlled trial
title The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
spellingShingle The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
Vanhaecht, Kris
Medicine (miscellaneous)
Pharmacology (medical)
title_short The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
title_full The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
title_fullStr The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
title_full_unstemmed The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
title_sort The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease
author Vanhaecht, Kris
author_facet Vanhaecht, Kris
Sermeus, Walter
Peers, Jan
Lodewijckx, Cathy
Deneckere, Svin
Leigheb, Fabrizio
Decramer, Marc
Panella, Massimiliano
Doocey, Antoinette
Boto, Paulo Alexandre Faria
Mendez, Rita Veloso
the EQCP Study Group
author_role author
author2 Sermeus, Walter
Peers, Jan
Lodewijckx, Cathy
Deneckere, Svin
Leigheb, Fabrizio
Decramer, Marc
Panella, Massimiliano
Doocey, Antoinette
Boto, Paulo Alexandre Faria
Mendez, Rita Veloso
the EQCP Study Group
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Escola Nacional de Saúde Pública (ENSP)
RUN
dc.contributor.author.fl_str_mv Vanhaecht, Kris
Sermeus, Walter
Peers, Jan
Lodewijckx, Cathy
Deneckere, Svin
Leigheb, Fabrizio
Decramer, Marc
Panella, Massimiliano
Doocey, Antoinette
Boto, Paulo Alexandre Faria
Mendez, Rita Veloso
the EQCP Study Group
dc.subject.por.fl_str_mv Medicine (miscellaneous)
Pharmacology (medical)
topic Medicine (miscellaneous)
Pharmacology (medical)
description Background: Hospital treatment of chronic obstructive pulmonary disease (COPD) frequently does not follow published evidences. This lack of adherence can contribute to the high morbidity, mortality and readmissions rates. The European Quality of Care Pathway (EQCP) study on acute exacerbations of COPD (NTC00962468) is undertaken to determine how care pathways (CP) as complex intervention for hospital treatment of COPD affects care variability, adherence to evidence based key interventions and clinical outcomes.Methods: An international cluster Randomized Controlled Trial (cRCT) will be performed in Belgium, Italy, Ireland and Portugal. Based on the power analysis, a sample of 40 hospital teams and 398 patients will be included in the study. In the control arm of the study, usual care will be provided. The experimental teams will implement a CP as complex intervention which will include three active components: a formative evaluation of the quality and organization of care, a set of evidence based key interventions, and support on the development and implementation of the CP. The main outcome will be six-month readmission rate. As a secondary endpoint a set of clinical outcome and performance indicators (including care process evaluation and team functioning indicators) will be measured in both groups.Discussion: The EQCP study is the first international cRCT on care pathways. The design of the EQCP project is both a research study and a quality improvement project and will include a realistic evaluation framework including process analysis to further understand why and when CP can really work.
publishDate 2010
dc.date.none.fl_str_mv 2010-11-19
2010-11-19T00:00:00Z
2018-06-21T22:07:14Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.1186/1745-6215-11-111
url https://doi.org/10.1186/1745-6215-11-111
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1745-6215
PURE: 4407843
http://www.scopus.com/inward/record.url?scp=78349261954&partnerID=8YFLogxK
https://doi.org/10.1186/1745-6215-11-111
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137935633678336